ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
WuXi AppTec
The Director of Technical Operations (MS&T) will provide scientific leadership for the CDMO drug‑product technical operations team, overseeing manufacturing and packaging of oral solid dosage and sterile products. The role is responsible for new product introduction, technology transfer, cleaning verification/validation, commercial project support, and regulatory audit and registration activities, ensuring compliance with GMP, FDA, EMA, and ICH standards.
WuXi AppTec is a global contract research, development and manufacturing organization (CRDMO) that provides integrated R&D and manufacturing services to pharmaceutical, biotech and medical device companies. Its offerings span discovery and preclinical research, clinical development support, analytical testing, and GMP manufacturing for small molecules, biologics, cell and gene therapies, and advanced therapeutics. With a worldwide network of labs and manufacturing facilities, WuXi positions itself as an end-to-end partner focused on accelerating drug development through scalable technology platforms, quality and regulatory expertise, and flexible outsourcing solutions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for WuXi AppTec.
WuXi AppTec didn’t post a salary, so this is our estimate from similar listings.
10% below the average for this role